NEW YORK (GenomeWeb News) – Vermillion and Accelerate Diagnostics saw their share prices more than double during the first six months of 2013, pacing the GenomeWeb Daily News Index for the first half of the year.

Overall, the index was up nearly 17 percent from the end of 2012, beating the Dow Jones Industrial Average (+14 percent) and the Nasdaq Composite (+13 percent), but trailing the Nasdaq Biotech Index (+27 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.